ChartMill assigns a Buy % Consensus number of 88% to DNTH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-14 | Truist Securities | Initiate | Buy |
| 2025-09-17 | Clear Street | Initiate | Buy |
| 2025-09-12 | Stifel | Maintains | Buy -> Buy |
| 2025-09-12 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-09 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-09-09 | Baird | Maintains | Outperform -> Outperform |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-21 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-02 | William Blair | Initiate | Outperform |
| 2025-05-13 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | TD Cowen | Initiate | Buy |
| 2024-11-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-10-03 | Oppenheimer | Initiate | Outperform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-07-26 | Baird | Initiate | Outperform |
| 2024-06-27 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-16 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-04-18 | Raymond James | Maintains | Outperform -> Outperform |
21 analysts have analysed DNTH and the average price target is 68.77 USD. This implies a price increase of 58.81% is expected in the next year compared to the current price of 43.3.
The consensus rating for DIANTHUS THERAPEUTICS INC (DNTH) is 87.619 / 100 . This indicates that analysts generally have a positive outlook on the stock.